Ze-jun Wang

No.1 Huangjin Industrial Park Road, Jiangxia District
Wuhan, 430207, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Discovery of a broad-spectrum monoclonal antibody recognizing a conserved, linear epitope WFYDGYPT on VP1 protein of Enterovirus A species.

Discovery of a broad-spectrum monoclonal antibody recognizing a conserved, linear epitope WFYDGYPT on VP1 protein of Enterovirus A species.

Journal: Virology journal

Published: September 14, 2024

Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters.

Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters.

Journal: Viruses

Published: March 07, 2024

Reporter Coxsackievirus A5 Expressing iLOV Fluorescent Protein or Luciferase Used for Rapid Neutralizing Assay in Cells and Living Imaging in Mice.

Reporter Coxsackievirus A5 Expressing iLOV Fluorescent Protein or Luciferase Used for Rapid Neutralizing Assay in Cells and Living Imaging in Mice.

Journal: Viruses

Published: August 08, 2023

Identification of a Conserved, Linear Epitope on VP3 of Enterovirus A Species Recognized by a Broad-Spectrum Monoclonal Antibody.

Identification of a Conserved, Linear Epitope on VP3 of Enterovirus A Species Recognized by a Broad-Spectrum Monoclonal Antibody.

Journal: Viruses

Published: March 27, 2023

Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice.

Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice.

Journal: Emerging microbes & infections

Published: November 14, 2022

Identification of specific and shared epitopes at the extreme N-terminal VP1 of Coxsackievirus A4, A2 and A5 by monoclonal antibodies.

Identification of specific and shared epitopes at the extreme N-terminal VP1 of Coxsackievirus A4, A2 and A5 by monoclonal antibodies.

Journal: Virus research

Published: October 31, 2022

Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.

Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.

Journal: Journal of virology

Published: March 28, 2022

Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain.

Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain.

Journal: Vaccine

Published: September 06, 2021

Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.

Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.

Journal: Emerging microbes & infections

Published: March 19, 2021

Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates.

Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates.

Journal: Virologica Sinica

Published: January 23, 2021

Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.

Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.

Journal: Emerging microbes & infections

Published: November 26, 2020

Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate.

Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate.

Journal: Emerging microbes & infections

Published: November 24, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026